Annual Accounts Payable
$535.00 K
-$181.00 K-25.28%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual accounts payable is $535.00 thousand, with the most recent change of -$181.00 thousand (-25.28%) on December 31, 2023.
- During the last 3 years, SCNI annual accounts payable has fallen by -$45.90 thousand (-7.90%).
- SCNI annual accounts payable is now -90.28% below its all-time high of $5.50 million, reached on December 1, 2018.
Performance
SCNI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$430.00 K
-$228.00 K-34.65%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly accounts payable is $430.00 thousand, with the most recent change of -$228.00 thousand (-34.65%) on September 1, 2024.
- Over the past year, SCNI quarterly accounts payable has dropped by -$498.00 thousand (-53.66%).
- SCNI quarterly accounts payable is now -92.19% below its all-time high of $5.50 million, reached on December 1, 2018.
Performance
SCNI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SCNI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.3% | -53.7% |
| 3 y3 years | -7.9% | -39.9% |
| 5 y5 years | -90.3% | -39.9% |
SCNI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.5% | at low | -67.3% | +45.4% |
| 5 y | 5-year | -89.1% | at low | -91.3% | +45.4% |
| alltime | all time | -90.3% | +394.9% | -92.2% | +430.2% |
Scinai Immunotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $430.00 K(-34.7%) |
| Jun 2024 | - | $658.00 K(-29.1%) |
| Mar 2024 | - | $928.00 K(+73.5%) |
| Dec 2023 | $535.00 K(-25.3%) | $535.00 K(-2.0%) |
| Sep 2023 | - | $546.00 K(-16.1%) |
| Jun 2023 | - | $651.00 K(-50.4%) |
| Mar 2023 | - | $1.31 M(+83.4%) |
| Dec 2022 | $716.00 K(-28.3%) | $716.00 K(+142.1%) |
| Sep 2022 | - | $295.70 K(-50.1%) |
| Jun 2022 | - | $592.40 K(-54.1%) |
| Mar 2022 | - | $1.29 M(+29.1%) |
| Dec 2021 | $999.00 K(+72.0%) | - |
| Dec 2021 | - | $999.00 K(-2.9%) |
| Sep 2021 | - | $1.03 M(+27.1%) |
| Jun 2021 | - | $809.30 K(+29.6%) |
| Mar 2021 | - | $624.40 K(+7.5%) |
| Dec 2020 | $580.90 K(-88.2%) | $580.90 K(-75.6%) |
| Sep 2020 | - | $2.38 M(+101.7%) |
| Jun 2020 | - | $1.18 M(+28.6%) |
| Mar 2020 | - | $918.10 K(-81.4%) |
| Dec 2019 | $4.93 M | $4.93 M(+1006.0%) |
| Sep 2019 | - | $445.50 K(-80.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $2.23 M(-46.9%) |
| Mar 2019 | - | $4.20 M(-23.6%) |
| Dec 2018 | $5.50 M(+207.3%) | $5.50 M(+1047.8%) |
| Sep 2018 | - | $479.40 K(+32.5%) |
| Jun 2018 | - | $361.70 K(-85.1%) |
| Mar 2018 | - | $2.43 M(+35.6%) |
| Dec 2017 | $1.79 M(+904.2%) | $1.79 M(+697.9%) |
| Sep 2017 | - | $224.40 K(-34.1%) |
| Jun 2017 | - | $340.60 K(+64.1%) |
| Mar 2017 | - | $207.50 K(+16.4%) |
| Dec 2016 | $178.30 K(-25.2%) | $178.30 K(+40.4%) |
| Sep 2016 | - | $127.00 K(+7.2%) |
| Jun 2016 | - | $118.50 K(-46.4%) |
| Mar 2016 | - | $221.10 K(-7.3%) |
| Dec 2015 | $238.50 K(+77.2%) | $238.50 K(+64.1%) |
| Sep 2015 | - | $145.30 K(-13.5%) |
| Jun 2015 | - | $168.00 K(-14.1%) |
| Mar 2015 | - | $195.60 K(+45.3%) |
| Dec 2014 | $134.60 K(+19.5%) | $134.60 K(+66.0%) |
| Sep 2014 | - | $81.10 K(-28.0%) |
| Dec 2013 | $112.60 K(+4.2%) | $112.60 K |
| Dec 2012 | $108.10 K | - |
FAQ
- What is Scinai Immunotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual accounts payable year-on-year change?
- What is Scinai Immunotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly accounts payable year-on-year change?
What is Scinai Immunotherapeutics annual accounts payable?
The current annual accounts payable of SCNI is $535.00 K
What is the all time high annual accounts payable for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual accounts payable is $5.50 M
What is Scinai Immunotherapeutics annual accounts payable year-on-year change?
Over the past year, SCNI annual accounts payable has changed by -$181.00 K (-25.28%)
What is Scinai Immunotherapeutics quarterly accounts payable?
The current quarterly accounts payable of SCNI is $430.00 K
What is the all time high quarterly accounts payable for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly accounts payable is $5.50 M
What is Scinai Immunotherapeutics quarterly accounts payable year-on-year change?
Over the past year, SCNI quarterly accounts payable has changed by -$498.00 K (-53.66%)